Forecast: Business Enterprise R&D Expenditure in Manufacture of Irradiation, Electromedical and Electrotherapeutic Equipment in the US

In 2023, business enterprise R&D expenditure in the manufacture of irradiation, electromedical, and electrotherapeutic equipment was 2.09 billion USD. Forecasts indicate a significant decline from 2024, with values dropping steadily to 0.649 billion USD by 2028. Year-on-year variation shows a progressive decline: -16.11% in 2025, -19.20% in 2026, -23.53% in 2027, and -30.40% in 2028. This results in a compound annual growth rate (CAGR) of approximately -16.8% over five years.

Future trends to watch for include:

  • Technological advancements and their potential to revitalize R&D investment.
  • Regulatory impacts influencing the industry.
  • Emerging markets or new applications creating fresh investment opportunities.

Top Countries about Research And Development